Links to publications that use this kit:
Derosa, G., Cicero, A. F. G., D'Angelo, A., Fogari, E. and Maffioli, P. (2012), Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes.
J Clin Pharm Ther. 2012 Apr;37(2):187-95. doi: 10.1111/j.1365-2710.2011.01280.x. Epub 2011 Aug 4.
Minako Yamaoka-Tojo et al., levated concentrations of retinol-binding protein-4 (RBP-4) in gestational diabetes mellitus: Negative correlation with soluble vascular cell adhesion molecule-1 (sVCAM-1)
Gynecological Endocrinology | June 1, 2008
Krzyzanowska et al. Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes.
Diabetologia. 2008 Jul;51(7):1115-22.
Reinehr et al. Retinol-binding protein 4 and its relation to insulin resistance in obese children before and after weight loss.
J Clin Endocrinol Metab. 2008 Jun;93(6):2287-93.
Tan et al. Raised Serum, Adipocyte, and Adipose Tissue Retinol-Binding Protein 4 in Overweight Women with Polycystic Ovary Syndrome: Effects of Gonadal and Adrenal Steroids
J Clin Endocrinol Metab. 2007 Jul;92(7):2764-72.
Takebayashi et al. Retinol Binding Protein-4 Levels and Clinical Features of Type 2 Diabetes Patients
J Clin Endocrinol Metab. 2007 Jul;92(7):2712-9.
Moro et al. Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue.
Diabetologia. 2007 May;50(5):1038-47.
Haider et al. Effect of rosiglitazone on visfatin and retinol-binding protein-4 plasma concentrations in HIV-positive patients.
Clin Pharmacol Ther. 2007 Apr;81(4):580-5.
Schindler et al. Impact of antiretroviral therapy on visfatin and retinol-binding protein 4 in HIV-infected subjects.
Eur J Clin Invest. 2006 Sep;36(9):640-6.
